Skip to main content
About Us > Mark Pohlkamp

Mark Pohlkamp

Consulting Product Placement Director

Mr. Mark Pohlkamp

Mark is a highly experienced senior executive in the electronic medical record space. Previously started a technology firm and exited that firm.  Experiences include working with publishing firms such as Elsevier®.  Also has executive experience working with firms such as Autodesk®.  He has a mechanical engineering degree from University of Missouri and an MBA from Xavier University.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange